The market for pharmaceuticals is evolving, with heightened requirements for economic and clinical value, intensifying competition, rapidly changing technologies, and greater regulatory scrutiny. Companies need to evolve their organizational infrastructure – the roles, accountabilities, processes, and capabilities that connect strategy to operations – to keep up with the changing environment.

The organizational implications are extensive. Strategies must integrate a broader range of functional perspectives, from R&D to commercial. Portfolio management and product development decisions must reflect new criteria. New skills must be developed to ensure that a strong value story can be defined, supported, and communicated effectively to institutional buyers.

Managing these shifts requires a great deal of coordination and change. That’s why Numerof takes a systematic approach to enhancing infrastructure in support of strategy. We start where our clients need to, whether that means addressing specific process gaps or broader efforts to transform departments or even entire organizations. Numerof’s proven, disciplined methodologies and understanding of organizational dynamics consistently deliver sustainable results.